Key result
CMR identifies acute myocarditis, MI, and convalescent dilated cardiomyopathy in symptomatic COVID-19 patients.
Why the study?
Cardiac magnetic resonance imaging findings in patients with COVID-19 presenting with cardiac problems at presentation and convalescence were not well described in this setting.
Observational (n=14)
No
CMR is a valuable imaging modality for identifying and differentiating cardiac pathologies such as myocarditis, myocardial infarction, and dilated cardiomyopathy in patients with COVID-19.
May support CMR for cardiac assessment in COVID-19; hypothesis-generating and should not yet change practice.
Purpose: Here, we describe cardiac magnetic resonance imaging (CMR) findings in patients with proven COVID-19 infection and presenting with cardiac problems both at presentation and in convalescence from a tertiary care center, in North India. A pertinent review of the literature is also discussed. Materials and Methods: Retrospective analysis of patients with real-time reverse transcriptase-polymerase chain reaction proven COVID-19 infection either at presentation or convalescence referred for CMR at our facility from January 2021 to December 2023 was done. CMR was performed on a 3T system (Ingenia, Philips Healthcare, Best, The Netherlands) and examinations were customized according to the clinical indications. Results: Retrospective analysis yielded 14 patients (4 at presentation; 10 in convalescence). Patients at presentation 4/14 had clinically presented with chest pain with raised troponins and electrographic abnormalities, while 10/14 patients had presented with clinical features of heart failure with two-dimensional transthoracic echocardiography demonstrating systolic dysfunction with reduced left ventricular ejection fraction. Out of 14, 4 patients at presentation, CMR showed features of acute myocarditis in three patients, while one had inferior wall myocardial infarction (MI) (this patient on catheter angiogram had aneurysmally dilated coronary arteries with thrombus and stenosis in the mid right coronary artery which was successfully stented). Out of 14, 10 patients on CMR had features of dilated cardiomyopathy (DCMP). Conclusion: Cardiac involvement in COVID-19 can have vivid clinicoradiological presentations with features of myocarditis and MI at presentation or DCMP in convalescence. CMR in such cases is a problem-solving tool where myocarditis is candidly differentiated from MI. Moreover, follow-up CMR demonstrates temporal changes in COVID-19-associated myocarditis and evaluation of cardiac structure and function in patients presenting with DCMP.
No takes yet. Share an insight, caveat, or question.
Singhal et al. (2024) conducted an observational in COVID-19 infection with cardiac problems (n=14). Cardiac magnetic resonance imaging (CMR) was evaluated on Cardiac magnetic resonance imaging findings. In 14 COVID-19 patients with cardiac symptoms, CMR identified acute myocarditis or myocardial infarction at presentation (n=4) and dilated cardiomyopathy in convalescence (n=10).
Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context: